Squarepoint’s Sanara MedTech SMTI Stock Holding History

Squarepoint’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Buy	73,607 +24,654	+50%	+$507K	﹤0.01%	2573
2025 Q4	$1.14M	Buy	48,953 +17,570	+56%	+$454K	﹤0.01%	2491
2025 Q3	$996K	Buy	31,383 +24,305	+343%	+$734K	﹤0.01%	2696
2025 Q2	$201K	Sell	7,078 -8,560	-55%	-$257K	﹤0.01%	3980
2025 Q1	$483K	Buy	15,638 +816	+6%	+$27.7K	﹤0.01%	3334
2024 Q4	$492K	Buy	14,822 +1,294	+10%	+$43.9K	﹤0.01%	3733
2024 Q3	$409K	Buy	+13,528	New	+$422K	﹤0.01%	3252

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Squarepoint's SMTI Position: Q1 2026 in Review

Squarepoint increased its Sanara MedTech (SMTI) stake by 50% in Q1 2026, buying an estimated $507K and bringing the position to 73,607 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Squarepoint first reported a position in SMTI in Q3 2024 and has held it in 7 quarters since. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Squarepoint held 73,607 shares of Sanara MedTech worth $1.26M as of Q1 2026.
Squarepoint bought 24,654 Sanara MedTech shares in Q1 2026, an estimated $507K.
Sanara MedTech made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2573 holding.
Squarepoint first reported a position in Sanara MedTech in Q3 2024 and has held it in 7 quarters since.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.